Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality
IntroductionPatients with COVID-19-related acute respiratory distress syndrome (ARDS) show limited systemic hyperinflammation, but immunomodulatory treatments are effective. Little is known about the inflammatory response in the lungs and if this could be targeted using high-dose steroids (HDS). We...
Saved in:
| Published in: | Thorax Vol. 78; no. 9; pp. 912 - 921 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BMJ Publishing Group Ltd and British Thoracic Society
01.09.2023
BMJ Publishing Group LTD |
| Subjects: | |
| ISSN: | 0040-6376, 1468-3296, 1468-3296 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!